The Claim
Dendritic cells within tumors in mice exhibit significantly higher expression of the creatine transporter gene compared to dendritic cells in healthy tissue, indicating a metabolic adaptation to energy stress in the tumor microenvironment.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice with tumors, dendritic cells show increased activity of the creatine transporter gene compared to dendritic cells in healthy tissue, reflecting a change in energy metabolism due to the tumor environment.
See the scientific wording
Dendritic cells within tumors in mice exhibit significantly higher expression of the creatine transporter gene compared to dendritic cells in healthy tissue, indicating a metabolic adaptation to energy stress in the tumor microenvironment.
Dendritic cells inside tumors take in more creatine because they need more energy to stay active. They use creatine to quickly make ATP, the energy currency of cells, which lets them signal to other immune cells and attack cancer. Without enough creatine, these dendritic cells cannot function properly and fail to activate the immune response.
What the research says
1 studyStudy: Unknown Title
Dendritic cells in tumors need more energy to fight cancer, and they use creatine like a fuel. The study shows that giving creatine helps these cells work better, which means they’re probably pulling in more creatine than normal—just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.